Delivery Order SPE2DR25D2005-SPE2DR26FE7A8
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $37,819.00 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This competitively awarded, firm fixed-price contract was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,017.61 on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract utilizes firm fixed pricing with no set-aside designation and is expected to be completed by November 6, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.22 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,594.36 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under the company's larger...
- The Defense Logistics Agency awarded a $136,951.37 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This is a firm fixed price delivery order issued without set-aside designation, indicating competitive award. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $44,398.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitive, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This delivery order, valued at $4,609.94, was awarded to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The Defense Logistics Agency (DLA), under the Department of Defense, issued this competitive award with firm fixed pricing and a completion date of November 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was issued under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $11,573.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $34,885.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with completion scheduled for November 6, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Repatha is a prescription medication used to treat high cholesterol, and the SureClick...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7A8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,236.44 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supplies. Executed on November 18, 2025, with an ultimate completion date of November 19, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical prime vendor agreement running through December 2026. This IDC serves as the comprehensive vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Under this delivery order, AmerisourceBergen supplies Repatha, a cardiovascular medication used to treat high cholesterol, to support Defense Health Agency and other federal healthcare system customers through the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/18/25 |